首页> 外文OA文献 >FRI0135 INTRAVENOUS PEGYLATED LIPOSOMAL PREDNISOLONE SODIUM PHOSPHATE MORE EFFECTIVE THAN INTRAMUSCULAR INJECTION OF METHYLPREDNISOLONE ACETATE IN TREATING RA PATIENTS WHO ARE EXPERIENCING A FLARE: A PHASE III, RANDOMIZED, DOUBLE-BLIND, DOUBLE DUMMY, ACTIVE CONTROLLED, MULTI-CENTER STUDY

【2h】

FRI0135 INTRAVENOUS PEGYLATED LIPOSOMAL PREDNISOLONE SODIUM PHOSPHATE MORE EFFECTIVE THAN INTRAMUSCULAR INJECTION OF METHYLPREDNISOLONE ACETATE IN TREATING RA PATIENTS WHO ARE EXPERIENCING A FLARE: A PHASE III, RANDOMIZED, DOUBLE-BLIND, DOUBLE DUMMY, ACTIVE CONTROLLED, MULTI-CENTER STUDY

机译：Fri0135静脉内聚乙二醇化脂质体泼尼松醇钠比肌内注射甲基己酮酸酐醋酸甲酸甲酯，在处理耀斑的RA患者中更有效：III期，随机，双盲，双假，有效控制，多中心研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

获取外文期刊封面目录资料

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Johannes W.J. Bijlsma; Bart Metselaar; Leonie Middelink; Cees Wortel; Reinhard Bos; Jacob M. van Laar; Harald Vonkeman; Rene Westhovens; Siu Long Yao; Mudgal Kothekar; Atul Raut;
展开▼
作者单位

展开▼
年度 2019
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献

1. Erratum: Golimumab, a new human anti–tumor necrosis factor antibody, administered intravenously in patients with active rheumatoid arthritis: Forty-eight–week efficacy and safety results of a phase III randomized, double-blind, placebo-controlled study [J] . li id=au1Joel Kremer li id=au2Christopher Ritchlin li id=au3Alan Mendelsohn li id=au4Daniel Baker li id=au5Lilianne Kim li id=au6Zhenhua Xu li id=au7John Han li id=au8Peter Taylor Arthritis & Rheumatism . 2010,第10期

机译：勘误：Golimumab，一种新型的人类抗肿瘤坏死因子抗体，在活动性类风湿关节炎患者中静脉给药：III期随机，双盲，安慰剂对照研究的48周疗效和安全性结果
2. Golimumab, a new human anti–tumor necrosis factor antibody, administered intravenously in patients with active rheumatoid arthritis: Forty-eight–week efficacy and safety results of a phase III randomized, double-blind, placebo-controlled study † [J] . Joel Kremer, Christopher Ritchlin, Alan Mendelsohn, Arthritis & Rheumatism . 2010,第4期

机译：Golimumab，一种新型的人类抗肿瘤坏死因子抗体，在活动性类风湿关节炎患者中静脉给药：III期随机，双盲，安慰剂对照研究的48周疗效和安全性结果†
3. Golimumab, a new human anti-tumor necrosis factor alpha antibody, administered intravenously in patients with active rheumatoid arthritis: Forty-eight-week efficacy and safety results of a phase III randomized, double-blind, placebo-controlled study. [J] . Kremer J, Ritchlin C, Mendelsohn A, Arthritis and Rheumatism . 2010,第4期

机译：戈利木单抗，一种新型的人类抗肿瘤坏死因子α抗体，在活动性类风湿性关节炎患者中静脉给药：III期随机，双盲，安慰剂对照研究的48周疗效和安全性结果。
4. MULTI-CENTER, PLACEBO-CONTROLLED, DOUBLE-BLIND, RANDOMIZED STUDY OF ORAL TOCERANIB PHOSPHATE (PALLADIATM, SU11654), A RECEPTOR TYROSINE KINASE INHIBITOR, FOR THE TREATMENT OF DOGS WITH RECURRENT MAS [C] . Cheryl L London, Carolyn J Henry, Anthony W Rusk, Annual conference of the Veterinary Cancer Society . 2008

机译：多中心，安慰剂对照，双盲，随机研究口服Toceranib磷酸盐（Palladia TM，SU11654），受体酪氨酸激酶抑制剂，用于治疗经常性MAS的狗
5. Feasibility randomised multicentre double-blind double-dummy controlled trial of anakinra an interleukin-1 receptor antagonist versus intramuscular methylprednisolone for acute gout attacks in patients with chronic kidney disease (ASGARD): protocol study [O] . Gowrie Balasubramaniam, Trisha Parker, David Turner, 2017

机译：anakinra（一种白介素1受体拮抗剂与肌内甲基强的松龙）在慢性肾脏疾病（ASGARD）患者中的急性痛风发作的可行性随机多中心双盲双模拟对照试验
6. Feasibility randomised multicentre, double-blind, double-dummy controlled trial of anakinra, an interleukin-1 receptor antagonist versus intramuscular methylprednisolone for acute gout attacks in patients with chronic kidney disease (ASGARD): protocol study [O] . Balasubramaniam Gowrie, Parker Trisha, Turner David, 2017

机译：anakinra（一种白介素1受体拮抗剂与肌内甲基强的松龙）在慢性肾脏病（ASGARD）患者中的急性痛风发作的可行性随机多中心，双盲，双模拟对照试验

FRI0135 INTRAVENOUS PEGYLATED LIPOSOMAL PREDNISOLONE SODIUM PHOSPHATE MORE EFFECTIVE THAN INTRAMUSCULAR INJECTION OF METHYLPREDNISOLONE ACETATE IN TREATING RA PATIENTS WHO ARE EXPERIENCING A FLARE: A PHASE III, RANDOMIZED, DOUBLE-BLIND, DOUBLE DUMMY, ACTIVE CONTROLLED, MULTI-CENTER STUDY

著录项

引文网络

相似文献

相关主题

期刊订阅